PCI Biotech Holding ASA reported earnings results for the fourth quarter ended December 31, 2021. For the fourth quarter, the company reported net loss was NOK 25.05 million compared to NOK 26.46 million a year ago. Basic loss per share from continuing operations was NOK 0.67 compared to NOK 0.71 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.6 NOK | -2.91% | +0.13% | -23.63% |
1st Jan change | Capi. | |
---|---|---|
-23.63% | 5.51M | |
+3.91% | 109B | |
+10.87% | 105B | |
+1.28% | 22.25B | |
-13.14% | 22.09B | |
-7.05% | 18.68B | |
-38.36% | 17.58B | |
-10.66% | 16.85B | |
+3.75% | 13.76B | |
+36.70% | 12.46B |
- Stock Market
- Equities
- PCIB Stock
- News PCI Biotech Holding ASA
- PCI Biotech Holding ASA Reports Earnings Results for the Fourth Quarter Ended December 31, 2021